Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. (DBTX) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 54 transactions totaling $75.9M, demonstrating a bullish sentiment with $75.7M in net insider flow. The most recent transaction on Sep 25, 2023 involved a transaction of 5,000 shares valued at $0.
DBTX Insider Activity Summary
Who Is Buying DBTX Stock?
No significant insider buying has been recorded for DBTX in the recent period.
Who Is Selling DBTX Stock?
No significant insider selling has been recorded for DBTX in the recent period.
Is Decibel Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DBTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $75.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
DBTX Frequently Asked Questions
Understanding DBTX Insider Activity
Insider trading at Decibel Therapeutics, Inc. (DBTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading DBTX stock, having executed 54 transactions in the past 90 days. The most active insider is Peter A. Thompson (Executive), who has made 5 transactions totaling $30.0M.
Related Tools
Track Decibel Therapeutics, Inc. Insider Activity
Get notified when executives and directors at DBTX file new Form 4 transactions